Related Experiment Video

Updated: May 9, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin

N Zhang1, X Wang1, Q Huo1

  • 1Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, China.

Oncogene
|July 16, 2013
PubMed

Insights

MicroRNA-30a (miR-30a) acts as a tumor suppressor in breast cancer, inhibiting cell growth and metastasis by targeting the MTDH gene. Lower miR-30a levels correlate with advanced metastasis, suggesting its potential as a prognostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in cancer, acting as oncogenes or tumor suppressors.
  • The specific role of miR-30a in breast cancer progression and metastasis requires further elucidation.

Purpose of the Study:

  • To investigate the function of miR-30a in breast cancer development and metastasis.
  • To identify the molecular targets of miR-30a in breast cancer.
  • To evaluate miR-30a as a potential biomarker and therapeutic target for breast cancer.

Main Methods:

  • In vitro studies using breast cancer cell lines to assess cell growth and metastasis upon miR-30a modulation.
  • In vivo xenograft mouse models to evaluate the effect of miR-30a on tumor growth and metastasis.
  • Dual luciferase reporter assays to confirm the direct interaction between miR-30a and the MTDH gene.
  • Analysis of miR-30a expression levels in patient-derived breast cancer tissues and correlation with clinical metastasis data.

Main Results:

  • Overexpression of miR-30a suppressed breast cancer cell proliferation and metastasis in vitro.
  • miR-30a inhibited tumor growth and lung metastasis in a xenograft mouse model.
  • miR-30a directly targets the 3'-untranslated region of the metadherin (MTDH) gene.
  • Silencing MTDH mimicked miR-30a's suppressive effects, while MTDH overexpression partially reversed them.
  • Lower miR-30a expression was observed in breast cancer tissues compared to normal tissues.
  • Reduced miR-30a levels correlated with increased lymph node and lung metastasis in patients.

Conclusions:

  • miR-30a functions as a tumor suppressor in breast cancer by inhibiting proliferation and metastasis through direct targeting of MTDH.
  • miR-30a serves as a potential prognostic biomarker for breast cancer metastasis.
  • Modulating miR-30a levels may offer a novel therapeutic strategy for breast cancer treatment.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...